首页 > 最新文献

Anaesthesia and Intensive Care Medicine最新文献

英文 中文
Electricity and the operating theatre: hazards and uses 电力和手术室:危害和用途
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.012
Dhaneesha Navin Sannasgala Senaratne, Michael Serpell
Electricity is a dangerous tool. When used carefully it can substantially improve safety, outcomes and efficiency within the operating theatre; but if used without due caution it can cause significant harm or death. Understanding the principles and practicalities of electrical supply, equipment design and safety mechanisms helps us identify and mitigate the risks to ourselves, our colleagues and our patients. Specific medical devices that apply current directly to the body for therapeutic effect (e.g. surgical diathermy, defibrillators) can be the most dangerous; if appropriate practices are not followed then the risk of electrical injury is high. In this article we cover the principles and knowledge required to ensure basic electrical safety within the operating theatre.
电是危险的工具。如果谨慎使用,它可以大大提高手术室的安全性、疗效和效率;但如果使用不当,可能会造成重大伤害或死亡。了解电力供应、设备设计和安全机制的原理和实用性,有助于我们识别和减轻对自己、同事和患者的风险。直接对身体施加电流以达到治疗效果的特定医疗装置(例如外科透热、除颤器)可能是最危险的;如果不遵循适当的做法,那么电气伤害的风险很高。在本文中,我们将介绍确保手术室内基本电气安全所需的原则和知识。
{"title":"Electricity and the operating theatre: hazards and uses","authors":"Dhaneesha Navin Sannasgala Senaratne,&nbsp;Michael Serpell","doi":"10.1016/j.mpaic.2025.05.012","DOIUrl":"10.1016/j.mpaic.2025.05.012","url":null,"abstract":"<div><div>Electricity is a dangerous tool. When used carefully it can substantially improve safety, outcomes and efficiency within the operating theatre; but if used without due caution it can cause significant harm or death. Understanding the principles and practicalities of electrical supply, equipment design and safety mechanisms helps us identify and mitigate the risks to ourselves, our colleagues and our patients. Specific medical devices that apply current directly to the body for therapeutic effect (e.g. surgical diathermy, defibrillators) can be the most dangerous; if appropriate practices are not followed then the risk of electrical injury is high. In this article we cover the principles and knowledge required to ensure basic electrical safety within the operating theatre.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 459-466"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airway management in the intensive care unit 重症监护病房的气道管理
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.004
Daniel Edelman, David. J. Brewster
Airway management practices in the intensive care unit (ICU) are still evolving, evidenced by an increasing proliferation of guidelines/algorithms in recent years as well ongoing studies focusing on equipment choices such as videolaryngoscopes. Specific considerations relate to the out-of-theatre environment and the physiological state in this patient population. Airway management in ICU is ultimately a multifaceted process spanning team training, simulation, preassessment, preparation, positioning of the patient, equipment decisions and guidelines/algorithm adherence including those covering the management of coronavirus disease (COVID-19). Emergency front-of-neck access (FONA) should be taught to all staff and standardized equipment made available. This updated article highlights the growing evidence supporting the use of videolaryngoscopy in the critical care setting as well as the use of checklists, and highlights the factors a multidisciplinary team must navigate when approaching airway management in the ICU.
重症监护病房(ICU)的气道管理实践仍在不断发展,近年来指南/算法的不断增加以及关注设备选择(如视频喉镜)的持续研究证明了这一点。具体考虑与院外环境和患者群体的生理状态有关。ICU的气道管理最终是一个多方面的过程,包括团队培训、模拟、预评估、准备、患者定位、设备决策和指南/算法遵守,包括涉及冠状病毒病(COVID-19)管理的指南/算法。应向所有工作人员传授紧急颈前通道,并提供标准化设备。这篇更新的文章强调了越来越多的证据支持在重症监护环境中使用视频喉镜检查以及使用检查清单,并强调了在ICU进行气道管理时多学科团队必须掌握的因素。
{"title":"Airway management in the intensive care unit","authors":"Daniel Edelman,&nbsp;David. J. Brewster","doi":"10.1016/j.mpaic.2025.05.004","DOIUrl":"10.1016/j.mpaic.2025.05.004","url":null,"abstract":"<div><div>Airway management practices in the intensive care unit (ICU) are still evolving, evidenced by an increasing proliferation of guidelines/algorithms in recent years as well ongoing studies focusing on equipment choices such as videolaryngoscopes. Specific considerations relate to the out-of-theatre environment and the physiological state in this patient population. Airway management in ICU is ultimately a multifaceted process spanning team training, simulation, preassessment, preparation, positioning of the patient, equipment decisions and guidelines/algorithm adherence including those covering the management of coronavirus disease (COVID-19). Emergency front-of-neck access (FONA) should be taught to all staff and standardized equipment made available. This updated article highlights the growing evidence supporting the use of videolaryngoscopy in the critical care setting as well as the use of checklists, and highlights the factors a multidisciplinary team must navigate when approaching airway management in the ICU.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 472-476"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-acquired pneumonia 社区获得性肺炎
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.013
Sjoerd HW van Bree, Shady Amer
Community-acquired pneumonia (CAP) is a condition characterized by inflammatory changes in the respiratory system caused by non-hospital pathogens. The symptoms and signs of a lower respiratory tract infection range from cough, dyspnoea, pleuritic chest pain, sputum with mucopurulent components, to systemic features such as myalgia, and fever. Patients in their older years are more likely to present with confusion or worsening pre-existing conditions and may lack fever. Severe CAP is a pneumonia that requires supportive therapy within intensive care settings, and is still associated with a high mortality and significantly morbidity, specifically amongst the elderly population with multiple comorbidities. Despite the improvement in supportive care by new modalities, such as high-flow nasal oxygen therapy, severe CAP remains one of the most common reasons for admission to a critical care facility. Correct diagnosis, risk stratification and early initiation of antibiotic treatment are key factors determining outcomes of patients with severe CAP. New developments will concentrate on diagnostics such as point of care microbiological tests and adjuvant non-antibiotic immunomodulating treatment strategies. Neither coronavirus disease (COVID-19) pneumonia nor pneumonia in immunocompromised patients are within the scope of this article.
社区获得性肺炎(CAP)是一种以非医院病原体引起的呼吸系统炎症变化为特征的疾病。下呼吸道感染的症状和体征包括咳嗽、呼吸困难、胸膜炎性胸痛、含黏液化脓性成分的痰,以及全身特征,如肌痛和发烧。老年患者更有可能出现精神错乱或既往疾病恶化,并可能不发烧。严重CAP是一种肺炎,需要在重症监护环境中进行支持性治疗,并且仍然与高死亡率和显著发病率相关,特别是在患有多种合并症的老年人群中。尽管支持治疗的新模式有所改善,如高流量鼻氧治疗,严重的CAP仍然是入院重症监护机构的最常见原因之一。正确的诊断、风险分层和早期开始抗生素治疗是决定严重CAP患者预后的关键因素。新的发展将集中在诊断上,如护理点微生物检测和辅助非抗生素免疫调节治疗策略。冠状病毒病(COVID-19)肺炎和免疫功能低下患者的肺炎均不在本文的讨论范围之内。
{"title":"Community-acquired pneumonia","authors":"Sjoerd HW van Bree,&nbsp;Shady Amer","doi":"10.1016/j.mpaic.2025.05.013","DOIUrl":"10.1016/j.mpaic.2025.05.013","url":null,"abstract":"<div><div>Community-acquired pneumonia (CAP) is a condition characterized by inflammatory changes in the respiratory system caused by non-hospital pathogens. The symptoms and signs of a lower respiratory tract infection range from cough, dyspnoea, pleuritic chest pain, sputum with mucopurulent components, to systemic features such as myalgia, and fever. Patients in their older years are more likely to present with confusion or worsening pre-existing conditions and may lack fever. Severe CAP is a pneumonia that requires supportive therapy within intensive care settings, and is still associated with a high mortality and significantly morbidity, specifically amongst the elderly population with multiple comorbidities. Despite the improvement in supportive care by new modalities, such as high-flow nasal oxygen therapy, severe CAP remains one of the most common reasons for admission to a critical care facility. Correct diagnosis, risk stratification and early initiation of antibiotic treatment are key factors determining outcomes of patients with severe CAP. New developments will concentrate on diagnostics such as point of care microbiological tests and adjuvant non-antibiotic immunomodulating treatment strategies. Neither coronavirus disease (COVID-19) pneumonia nor pneumonia in immunocompromised patients are within the scope of this article.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 491-497"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Field anaesthesia and critical care equipment used by the British military 英国军队使用的战地麻醉和重症监护设备
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.015
Emma Watson, Andy Lamb
This article describes and provides discussion about key equipment used by the UK Defence Medical Services (DMS) for field anaesthesia and critical care medicine. Field equipment must be both clinically effective and suitable for operation in a field environment, often resulting in a compromise. Field equipment must be robust, portable, simple to maintain, and require minimal consumables or parts.
本文描述并讨论了英国国防医疗服务(DMS)用于战地麻醉和重症监护医学的关键设备。现场设备必须既具有临床有效性,又适合在现场环境中操作,这往往会导致妥协。现场设备必须坚固,便携,易于维护,并且需要最少的消耗品或零件。
{"title":"Field anaesthesia and critical care equipment used by the British military","authors":"Emma Watson,&nbsp;Andy Lamb","doi":"10.1016/j.mpaic.2025.05.015","DOIUrl":"10.1016/j.mpaic.2025.05.015","url":null,"abstract":"<div><div>This article describes and provides discussion about key equipment used by the UK Defence Medical Services (DMS) for field anaesthesia and critical care medicine. Field equipment must be both clinically effective and suitable for operation in a field environment, often resulting in a compromise. Field equipment must be robust, portable, simple to maintain, and require minimal consumables or parts.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 528-531"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disinfection, sterilization and single use 消毒、灭菌、一次性使用
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.006
Michael G. Gardner, Michael Serpell
Healthcare-associated infections continue to place a significant burden on healthcare organizations with anaesthetic and intensive care practice contributing to this burden. Knowledge and understanding of methods to mitigate transmission is key to reducing its impact. Decontamination is the process where reusable medical devices are rendered safe for reuse through cleaning and then either disinfection or sterilization. Cleaning is the physical process of removing foreign matter from an object. Disinfection removes most, but not all microorganisms whilst sterilization eliminates all viable microorganisms. Single-use medical items are sterilized during manufacture and avoid the requirement for further decontamination altogether by being disposable.
与医疗保健相关的感染继续给医疗保健组织带来沉重的负担,麻醉和重症监护实践加剧了这一负担。了解和了解减轻传播的方法是减少其影响的关键。去污是指可重复使用的医疗设备通过清洁,然后消毒或灭菌,使其可以安全重复使用的过程。清洗是清除物体上异物的物理过程。消毒可以去除大部分但不是全部的微生物,而灭菌可以去除所有活的微生物。一次性医疗用品在生产过程中消毒,避免了进一步消毒的要求,因为它们是一次性的。
{"title":"Disinfection, sterilization and single use","authors":"Michael G. Gardner,&nbsp;Michael Serpell","doi":"10.1016/j.mpaic.2025.05.006","DOIUrl":"10.1016/j.mpaic.2025.05.006","url":null,"abstract":"<div><div>Healthcare-associated infections continue to place a significant burden on healthcare organizations with anaesthetic and intensive care practice contributing to this burden. Knowledge and understanding of methods to mitigate transmission is key to reducing its impact. Decontamination is the process where reusable medical devices are rendered safe for reuse through cleaning and then either disinfection or sterilization. Cleaning is the physical process of removing foreign matter from an object. Disinfection removes most, but not all microorganisms whilst sterilization eliminates all viable microorganisms. Single-use medical items are sterilized during manufacture and avoid the requirement for further decontamination altogether by being disposable.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 455-458"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144721429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asthma and chronic obstructive pulmonary disease in the intensive care unit 重症监护室的哮喘和慢性阻塞性肺病
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.008
Craig Johnston, Paul Nixon
The prevalence of asthma and chronic obstructive pulmonary disease is increasing worldwide. Patients who require intensive care management for acute exacerbations of these conditions represent a particular challenge. The requirement for invasive mechanical ventilation is associated with many pitfalls, as evidenced by the higher mortality rate of patients undergoing this intervention. This article describes the initial management, as well as escalating respiratory support and advanced pharmacological therapies, and the current evidence supporting these. In particular, the concept of dynamic hyperinflation is addressed as well as ventilation strategies that should be employed to prevent the development of complications.
在世界范围内,哮喘和慢性阻塞性肺病的患病率正在上升。这些疾病的急性恶化需要重症监护管理的患者是一个特别的挑战。有创机械通气的要求与许多缺陷相关,接受这种干预的患者死亡率较高就是证据。本文描述了最初的管理,以及不断升级的呼吸支持和先进的药物治疗,以及目前支持这些的证据。特别地,讨论了动态恶性通货膨胀的概念以及应该采用的通气策略,以防止并发症的发展。
{"title":"Asthma and chronic obstructive pulmonary disease in the intensive care unit","authors":"Craig Johnston,&nbsp;Paul Nixon","doi":"10.1016/j.mpaic.2025.05.008","DOIUrl":"10.1016/j.mpaic.2025.05.008","url":null,"abstract":"<div><div>The prevalence of asthma and chronic obstructive pulmonary disease is increasing worldwide. Patients who require intensive care management for acute exacerbations of these conditions represent a particular challenge. The requirement for invasive mechanical ventilation is associated with many pitfalls, as evidenced by the higher mortality rate of patients undergoing this intervention. This article describes the initial management, as well as escalating respiratory support and advanced pharmacological therapies, and the current evidence supporting these. In particular, the concept of dynamic hyperinflation is addressed as well as ventilation strategies that should be employed to prevent the development of complications.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 507-514"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute respiratory distress syndrome 急性呼吸窘迫综合征
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.010
Tapan Parikh aka Parmar, David Pilcher
Acute respiratory distress syndrome (ARDS) is a heterogeneous lung disease that is triggered by pulmonary and non-pulmonary pathologies. It predominantly causes hypoxaemic respiratory failure and can lead to significant morbidity and mortality. Although ARDS re-mains underdiagnosed, 24% of mechanically ventilated patients in intensive care units and 33% of coronavirus disease (COVID-19) patients admitted to the hospital are reported to have ARDS. Despite recent advances in treatment, mortality remains at more than 30% for all ARDS patients and 43% for severe ARDS.
The pathophysiology is complex and involves acute pulmonary and systemic inflammation, alveolar oedema, and de-recruitment which lead to ventilation-perfusion mismatch, reduced lung compliance and hypoxaemia. Similarities in the pathophysiology of COVID-19 ARDS outnumber differences from non-COVID-19 ARDS. Inhomogeneous distribution of transpulmonary pressure variation throughout the lungs in ARDS increases the risk of patient self-inflicted lung injury and ventilator-associated lung injury.
Stratifying ARDS patients as per new proposed global definition may ensure broader patient inclusion and support future research especially in under resource countries. Treating the underlying cause, lung-protective ventilation and supportive care are the mainstays of clinical management. Multiple rescue therapies, novel treatments, and methods of facilitating individualized ventilation especially based on phenotypes have been described but many require further validation; and appropriate patient selection is warranted.
急性呼吸窘迫综合征(ARDS)是一种由肺部和非肺部病变引发的异质性肺部疾病。它主要引起低氧性呼吸衰竭,并可导致显著的发病率和死亡率。尽管ARDS仍未得到充分诊断,但据报道,重症监护病房24%的机械通气患者和33%的冠状病毒病(COVID-19)住院患者患有ARDS。尽管最近在治疗方面取得了进展,但所有ARDS患者的死亡率仍然超过30%,严重ARDS患者的死亡率为43%。病理生理学是复杂的,涉及急性肺部和全身炎症、肺泡水肿和肺再招募减少,导致通气-灌注失配、肺顺应性降低和低氧血症。COVID-19 - ARDS在病理生理上的相似性大于与非COVID-19 - ARDS的差异。急性呼吸窘迫综合征患者全肺经肺压变化的不均匀分布增加了患者自身肺损伤和呼吸机相关肺损伤的风险。根据新提出的全球定义对ARDS患者进行分层可以确保更广泛的患者纳入,并支持未来的研究,特别是在资源不足的国家。治疗病因、肺保护性通气和支持性护理是临床治疗的主要内容。多种抢救疗法、新疗法和促进个体化通气的方法,特别是基于表型的方法已经被描述,但许多需要进一步验证;适当的病人选择是有保证的。
{"title":"Acute respiratory distress syndrome","authors":"Tapan Parikh aka Parmar,&nbsp;David Pilcher","doi":"10.1016/j.mpaic.2025.05.010","DOIUrl":"10.1016/j.mpaic.2025.05.010","url":null,"abstract":"<div><div>Acute respiratory distress syndrome (ARDS) is a heterogeneous lung disease that is triggered by pulmonary and non-pulmonary pathologies. It predominantly causes hypoxaemic respiratory failure and can lead to significant morbidity and mortality. Although ARDS re-mains underdiagnosed, 24% of mechanically ventilated patients in intensive care units and 33% of coronavirus disease (COVID-19) patients admitted to the hospital are reported to have ARDS. Despite recent advances in treatment, mortality remains at more than 30% for all ARDS patients and 43% for severe ARDS.</div><div>The pathophysiology is complex and involves acute pulmonary and systemic inflammation, alveolar oedema, and de-recruitment which lead to ventilation-perfusion mismatch, reduced lung compliance and hypoxaemia. Similarities in the pathophysiology of COVID-19 ARDS outnumber differences from non-COVID-19 ARDS. Inhomogeneous distribution of transpulmonary pressure variation throughout the lungs in ARDS increases the risk of patient self-inflicted lung injury and ventilator-associated lung injury.</div><div>Stratifying ARDS patients as per new proposed global definition may ensure broader patient inclusion and support future research especially in under resource countries. Treating the underlying cause, lung-protective ventilation and supportive care are the mainstays of clinical management. Multiple rescue therapies, novel treatments, and methods of facilitating individualized ventilation especially based on phenotypes have been described but many require further validation; and appropriate patient selection is warranted.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 515-522"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk assessment in anaesthesia for adult non-cardiac surgery 成人非心脏手术麻醉的风险评估
IF 0.3 Q4 ANESTHESIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.mpaic.2025.05.009
Carmen Leung, Yiu Chung Lau
Risk assessment is crucial in perioperative care planning to optimize outcomes. Various risk assessment tools have been developed to predict the general risk of surgery and specific system-based risks. Guidelines recommend using these tools to stratify risk of perioperative complications. Cardiac biomarkers may supplement risk assessment for high-risk patients. Investigations including cardiopulmonary exercise testing and pulmonary function tests are reserved for high-risk patients and procedures. Frailty is an independent predictor of adverse outcomes and should be screened routinely preoperatively in elderly patients. Each risk prediction tool has its own limitations and there is a lack of evidence to suggest one over another. Further research on these tools and artificial intelligence could improve subsequent clinical decision-making.
风险评估是围手术期护理计划优化结果的关键。已经开发了各种风险评估工具来预测手术的一般风险和特定的系统风险。指南建议使用这些工具对围手术期并发症的风险进行分层。心脏生物标志物可以补充高危患者的风险评估。包括心肺运动测试和肺功能测试在内的调查是为高危患者和手术保留的。虚弱是不良结果的独立预测因子,应在老年患者术前常规筛查。每一种风险预测工具都有其自身的局限性,而且缺乏证据表明它们孰优孰劣。对这些工具和人工智能的进一步研究可以改善后续的临床决策。
{"title":"Risk assessment in anaesthesia for adult non-cardiac surgery","authors":"Carmen Leung,&nbsp;Yiu Chung Lau","doi":"10.1016/j.mpaic.2025.05.009","DOIUrl":"10.1016/j.mpaic.2025.05.009","url":null,"abstract":"<div><div>Risk assessment is crucial in perioperative care planning to optimize outcomes. Various risk assessment tools have been developed to predict the general risk of surgery and specific system-based risks. Guidelines recommend using these tools to stratify risk of perioperative complications. Cardiac biomarkers may supplement risk assessment for high-risk patients. Investigations including cardiopulmonary exercise testing and pulmonary function tests are reserved for high-risk patients and procedures. Frailty is an independent predictor of adverse outcomes and should be screened routinely preoperatively in elderly patients. Each risk prediction tool has its own limitations and there is a lack of evidence to suggest one over another. Further research on these tools and artificial intelligence could improve subsequent clinical decision-making.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 8","pages":"Pages 467-471"},"PeriodicalIF":0.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs affecting the autonomic nervous system 影响自主神经系统的药物
IF 0.2 Q4 ANESTHESIOLOGY Pub Date : 2025-06-12 DOI: 10.1016/j.mpaic.2025.04.007
Reya Vinay Shah, Cleodie Swire, Rhiann Marie O'Shaughnessy, Fu Liang Ng
The autonomic nervous system comprises sympathetic and parasympathetic systems. Together, they modulate a variety of physiological functions in order to maintain homeostasis. Many commonly used medicines have direct or indirect effects upon this system and understanding of autonomic pharmacology is vital to use these medicines safely and effectively in clinical practice.
自主神经系统包括交感神经系统和副交感神经系统。它们共同调节各种生理功能以维持体内平衡。许多常用药物对该系统有直接或间接的影响,了解自主药理学对于在临床实践中安全有效地使用这些药物至关重要。
{"title":"Drugs affecting the autonomic nervous system","authors":"Reya Vinay Shah,&nbsp;Cleodie Swire,&nbsp;Rhiann Marie O'Shaughnessy,&nbsp;Fu Liang Ng","doi":"10.1016/j.mpaic.2025.04.007","DOIUrl":"10.1016/j.mpaic.2025.04.007","url":null,"abstract":"<div><div>The autonomic nervous system comprises sympathetic and parasympathetic systems. Together, they modulate a variety of physiological functions in order to maintain homeostasis. Many commonly used medicines have direct or indirect effects upon this system and understanding of autonomic pharmacology is vital to use these medicines safely and effectively in clinical practice.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 7","pages":"Pages 446-451"},"PeriodicalIF":0.2,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144491166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain management in palliative care: art or science 姑息治疗中的疼痛管理:艺术还是科学
IF 0.2 Q4 ANESTHESIOLOGY Pub Date : 2025-06-06 DOI: 10.1016/j.mpaic.2025.04.003
Brigid Bassam
Pain management in palliative care is both an art and a science. Essential to good pain control is an understanding not only of the pathophysiology of the origin of the pain, but also the impact that the pain is having, as the palliative patient may have to live with the symptoms of disease for months or even years. Interventions can then be targeted and at various times, may include a range of pharmacological treatments, psychological or spiritual support and possibly the involvement of other specialties to alleviate a particular problem.
姑息治疗中的疼痛管理既是一门艺术也是一门科学。良好的疼痛控制至关重要的是,不仅要了解疼痛起源的病理生理学,还要了解疼痛所产生的影响,因为姑息治疗患者可能不得不带着疾病的症状生活数月甚至数年。干预可以在不同的时间有针对性地进行,可能包括一系列药物治疗,心理或精神支持,可能还包括其他专业的参与,以缓解特定的问题。
{"title":"Pain management in palliative care: art or science","authors":"Brigid Bassam","doi":"10.1016/j.mpaic.2025.04.003","DOIUrl":"10.1016/j.mpaic.2025.04.003","url":null,"abstract":"<div><div>Pain management in palliative care is both an art and a science. Essential to good pain control is an understanding not only of the pathophysiology of the origin of the pain, but also the impact that the pain is having, as the palliative patient may have to live with the symptoms of disease for months or even years. Interventions can then be targeted and at various times, may include a range of pharmacological treatments, psychological or spiritual support and possibly the involvement of other specialties to alleviate a particular problem.</div></div>","PeriodicalId":45856,"journal":{"name":"Anaesthesia and Intensive Care Medicine","volume":"26 7","pages":"Pages 400-405"},"PeriodicalIF":0.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144491161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anaesthesia and Intensive Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1